References
- Aalen, O. O., Borgan, O., and Gjessing, H. (2008), “Unobserved Heterogeneity: The Odd Effects of Frailty” (Chapter 6), in Survival and Event History Analysis: A Process Point of View, New York: Springer Science & Business Media, pp. 231–270.
- Aalen, O. O., Cook, R. J., and Røysland, K. (2015), “Does Cox Analysis of a Randomized Survival Study Yield a Causal Treatment Effect?,” Lifetime Data Analysis, 21, 579–593. DOI: 10.1007/s10985-015-9335-y.
- Hernán, M. A. (2010), “The Hazards of Hazard Ratios,” Epidemiology, 21, 13–15.
- Hernán, M. A., and Robins, J. M. (2020), Causal Inference: What If, Boca Raton, FL: Chapman & Hall/CRC.
- ICH E9 (R1) (2019), “ICH E9 (R1) Addendum on Estimands and Sensitivity Analysis in Clinical Trials to the Guideline on Statistical Principles for Clinical Trials,” available at https://database.ich.org/sites/default/files/E9-R1_Step4_Guideline_2019_1203.pdf.
- Lin, R. S., and León, L. F. (2017), “Estimation of Treatment Effects in Weighted Log-Rank Tests,” Contemporary Clinical Trials Communications, 8, 147–155. DOI: 10.1016/j.conctc.2017.09.004.
- Lin, R. S., Lin, J., Roychoudhury, S., Anderson, K. M., Hu, T., Huang, B., Leon, L. F., Liao, J. J., Liu, R., Luo, X., and Mukhopadhyay, P. (2019), “Alternative Analysis Methods for Time to Event Endpoints Under Non-Proportional Hazards: A Comparative Analysis,” Statistics in Biopharmaceutical Research, 12, 187–198, DOI: 10.1080/19466315.2019.1697738.
- Magirr, D., and Burman, C. F. (2019), “Modestly Weighted Logrank Tests,” Statistics in Medicine, 38, 3782–3790. DOI: 10.1002/sim.8186.
- Martinussen, T., Vansteelandt, S., and Andersen, P. K. (2018), “Subtleties in the Interpretation of Hazard Ratios,” arXiv no. 1810.09192.
- Stensrud, M. J., Aalen, J. M., Aalen, O. O., and Valberg, M. (2019), “Limitations of Hazard Ratios in Clinical Trials,” European Heart Journal, 40, 1378–1383. DOI: 10.1093/eurheartj/ehy770.